Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
NOT YET RECRUITING
NCT05175651
NA
Prospective Electronic Polygenic Risk Study - Second Phase
Sponsor: Scripps Translational Science Institute
View on ClinicalTrials.gov
Summary
This study will investigate the role of polygenic risk scores (PRS) in preventive health.
Key Details
Gender
All
Age Range
45 Years - 65 Years
Study Type
INTERVENTIONAL
Enrollment
10000
Start Date
2023-06
Completion Date
2027-01-15
Last Updated
2022-11-07
Healthy Volunteers
No
Conditions
Interventions
BEHAVIORAL
Genetic risk assessment
A coronary artery disease (CAD) and glaucoma polygenic risk scores (PRS) will be calculated for all study participants, with participants randomized to receiving either their CAD or glaucoma PRS.